Loading...
Gremubamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Bradyrhizobium sp. PcrV, Gremubamab is under investigation in clinical trial NCT02255760 (Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults).
Biosimilars
Human
Monoclonal
Human
Bradyrhizobium sp. PcrV
Human
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1800381-36-5
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más